INSIGHTS ON ENTERPRISE SOLUTIONS
-
60-Seconds Of Science: Optimizing Complex Molecule Production
A principal scientist shares how his team overcame key manufacturing challenges in complex bispecific antibody production, highlighting problem-solving strategies and impressive results in this concise educational video.
-
60-Seconds Of Science
Explore the complex biologics journey, featuring expert-led discussions on development, analytics, MSAT, and tech transfer, offering concise, practical insights for busy professionals worldwide.
-
FIH: Reach Milestones Sooner With A Technology-Driven Approach
Accelerate your path to IND and FiH with AI-driven design, advanced cell line engineering, and intensified processes delivering high titers in 9–14 months.
-
What's The Real Challenge In Biologic Manufacturing Scale-up? It's Not Capacity — It's Demand
As you plan your next stage of scale-up, take a moment to evaluate whether your manufacturing strategy is built around capacity — or around evolving market demand.
-
Flexibility Or Scale? Navigating The Single Use Vs. Stainless Steel Debate2/12/2026
Explore how to choose between single‑use and stainless‑steel bioreactors, outlining key advantages, limitations, and long‑term considerations essential for successful biologics scale‑up.
-
Project Management: The Conductor Behind Every Successful CDMO Program2/12/2026
Understand how elite CDMO project management acts as a conductor—integrating molecule expertise, rigorous readiness, and disciplined GMP execution to drive successful biologics manufacturing programs.
-
The Future Of RNA Manufacturing Starts With Raw Material Innovation2/11/2026
Amid the mRNA and oligonucleotide therapeutic boom, sponsors and manufacturers are exploring how to make critical raw materials—capping agents, lipid nanoparticles, and RNA polymerase—more effective.
-
Preparing Pharma Operations For An Autonomous Future2/6/2026
Biopharma’s push for faster delivery is accelerating a shift from automated to autonomous manufacturing. Explore how deeper connectivity and self‑optimizing systems are shaping the next frontier.
ENTERPRISE SOLUTIONS
-
Unlike traditional CDMOs that stitch services together, Thermo Fisher Scientific connects our capabilities to streamline biologics development through Path to First-in-Human.
-
Accelerate your biologics program with an integrated discovery‑to‑development partner built to deliver high‑quality candidates with speed and scientific rigor.
-
The Curia Antibody Center offers a comprehensive suite of services for researchers seeking the discovery and engineering of potent and functional antibodies.
-
Accelerate sterile injectable development with expert support, advanced facilities, and tailored solutions for complex APIs — from formulation through commercialization across small molecules and biologics.
-
A practical, vendor-neutral, two-day workshop focused on improving granulation and tablet manufacturing performance through live demos and OEM-led instruction.